Efficacy of on-demand asimadoline, a peripheral kappa-opioid agonist, in females with irritable bowel syndrome (Q24684839)

1

Lawrence A Szarka

0 references

Michael Camilleri

2

Michael Camilleri

0 references

Sanna McKinzie

5

Sanna McKinzie

0 references

Duane Burton

3

Duane Burton

0 references

Jean-Paul Fox

4

Jean C Fox

0 references

Julie Simonson

7

Julie Simonson

0 references

author name string

Timothy Stanislav

6

0 references

Nancy Sullivan

Clinical Gastroenterology and Hepatology

8

0 references

language of work or name

English

0 references

publication date

November 2007

0 references

published in

0 references

volume

5

0 references

issue

11

0 references

page(s)

1268-75

0 references

cites work

kappa-Opioid receptor in humans: cDNA and genomic cloning, chromosomal assignment, functional expression, pharmacology, and expression pattern in the central nervous system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2128734

The hospital anxiety and depression scale

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2128734

The burden of illness of irritable bowel syndrome: current challenges and hope for the future

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2128734

Irritable bowel syndrome: recent and novel therapeutic approaches

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2128734

Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2128734

Effect of asimadoline, a kappa opioid agonist, on pain induced by colonic distension in patients with irritable bowel syndrome

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2128734

Effects of a kappa-opioid agonist, asimadoline, on satiation and GI motor and sensory functions in humans

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2128734

Irritable bowel syndrome neuropharmacology. A review of approved and investigational compounds

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2128734

Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2128734

Molecular pharmacology of the opioid receptors.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2128734

The control of pain in peripheral tissue by opioids.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2128734

Efficacy of peripheral kappa agonist fedotozine versus placebo in treatment of irritable bowel syndrome. A multicenter dose-response study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2128734

Opioids can evoke direct receptor-mediated excitatory effects on sensory neurons

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2128734

How bad are the symptoms and bowel dysfunction of patients with the irritable bowel syndrome? A prospective, controlled study with emphasis on stool form

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2128734

Effects of kappa-opioid receptor agonists on responses to colorectal distension in rats with and without acute colonic inflammation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2128734

A pharmacological profile of the novel, peripherally-selective kappa-opioid receptor agonist, EMD 61753.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2128734

Heightened visceral sensation in functional gastrointestinal disease is not site-specific. Evidence for a generalized disorder of gut sensitivity

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2128734

Effects of asimadoline, a kappa-opioid agonist, on satiation and postprandial symptoms in health

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2128734

Recombinant human neurotrophic factors accelerate colonic transit and relieve constipation in humans

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2128734

Peripheral effects of the kappa-opioid agonist EMD 61753 on pain and inflammation in rats and humans.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2128734

Functional dyspepsia and irritable bowel syndrome: is there a common pathophysiological basis?

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2128734

kappa-Opioid activity of the four stereoisomers of the peripherally selective kappa-agonists, EMD 60,400 and EMD 61,753.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2128734

Irritable bowel syndrome symptom patterns: frequency, duration, and severity

28 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17900994

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

"Kapping" visceral pain in patients with irritable bowel syndrome: does it work?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17900994

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Quality of life in persons with irritable bowel syndrome: development and validation of a new measure

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17900994

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.CGH.2007.07.011

1 reference

1 reference

1 reference

PubMed publication ID

17900994

1 reference